These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23878932)

  • 41. First-In-Class Inhibitors Targeting the Interaction between Bacterial RNA Polymerase and Sigma Initiation Factor Affect the Viability and Toxin Release of
    Ye J; Chu AJ; Lin L; Yang X; Ma C
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31405060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Streptococcus pneumoniae and reactive oxygen species: an unusual approach to living with radicals.
    Yesilkaya H; Andisi VF; Andrew PW; Bijlsma JJ
    Trends Microbiol; 2013 Apr; 21(4):187-95. PubMed ID: 23415028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay.
    Peterson EJ; Kireev D; Moon AF; Midon M; Janzen WP; Pingoud A; Pedersen LC; Singleton SF
    J Biomol Screen; 2013 Mar; 18(3):247-57. PubMed ID: 23015019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a protein that inactivates the competence-stimulating peptide of Streptococcus pneumoniae.
    Bergé M; Langen H; Claverys JP; Martin B
    J Bacteriol; 2002 Jan; 184(2):610-3. PubMed ID: 11751845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dirhodium (II) complex interferes with iron-transport system to exert antibacterial action against Streptococcus pneumoniae.
    Yang XY; Xu JY; Meng M; Li N; Liu CY; He QY
    J Proteomics; 2019 Mar; 194():160-167. PubMed ID: 30521977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of protein expression of Streptococcus pneumoniae by blood.
    Bae SM; Yeon SM; Kim TS; Lee KJ
    J Biochem Mol Biol; 2006 Nov; 39(6):703-8. PubMed ID: 17129405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The selective advantage of microbial fratricide.
    Gilmore MS; Haas W
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8401-2. PubMed ID: 15939890
    [No Abstract]   [Full Text] [Related]  

  • 48. Streptococcus pneumoniae G5 domains bind different ligands.
    Paukovich N; Redzic JS; Chi YC; Rahkola JT; Issaian A; Blue A; Hansen KC; Janoff EN; Eisenmesser EZ
    Protein Sci; 2019 Oct; 28(10):1797-1805. PubMed ID: 31390088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 'captain of the men of death', Streptococcus pneumoniae, fights oxidative stress outside the 'city wall'.
    Gennaris A; Collet JF
    EMBO Mol Med; 2013 Dec; 5(12):1798-800. PubMed ID: 24293314
    [No Abstract]   [Full Text] [Related]  

  • 50. Microbiology: A beacon for bacterial tubulin.
    Harry EJ
    Nature; 2014 Dec; 516(7530):175-6. PubMed ID: 25470050
    [No Abstract]   [Full Text] [Related]  

  • 51. Mapping mid-cell: MapZ shows the way.
    Grangeasse C; Lesterlin C
    Cell Cycle; 2015; 14(7):937-8. PubMed ID: 25803432
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target.
    Hervin V; Roy V; Agrofoglio LA
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BoBER: web interface to the base of bioisosterically exchangeable replacements.
    Lešnik S; Škrlj B; Eržen N; Bren U; Gobec S; Konc J; Janežič D
    J Cheminform; 2017 Dec; 9(1):62. PubMed ID: 29234984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurF.
    Comess KM; Schurdak ME; Voorbach MJ; Coen M; Trumbull JD; Yang H; Gao L; Tang H; Cheng X; Lerner CG; McCall JO; Burns DJ; Beutel BA
    J Biomol Screen; 2006 Oct; 11(7):743-54. PubMed ID: 16973923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets.
    Sham LT; Tsui HC; Land AD; Barendt SM; Winkler ME
    Curr Opin Microbiol; 2012 Apr; 15(2):194-203. PubMed ID: 22280885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical characterization of MurF from Streptococcus pneumoniae and the identification of a new MurF inhibitor through ligand-based virtual screening.
    Turk S; Hrast M; Sosic I; Barreteau H; Mengin-Lecreulx D; Blanot D; Gobec S
    Acta Chim Slov; 2013; 60(2):294-9. PubMed ID: 23878932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.